Clinical Trials
Source: CCM
- Score: 4Headaches
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)
- Ages6 years - 17 years
- GenderBoth
- Score: 3Children's Health, Headaches
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)
- Ages6 years - 17 years
- GenderBoth
- Score: 0COVID-19 Outpatient
Are you are currently experiencing brain fog from Long COVID?